Marker Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Marker Therapeutics Inc capital reinvestment ratio. Marker Therapeutics Inc (MRKR) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($1.20 Million) in capital expenditures ($1.00). Check MRKR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$1.20 Million

USD

Capital Expenditures

$1.00

USD

Data as of

Sep 2024

Most recent filing

Marker Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Marker Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Marker Therapeutics Inc (MRKR) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow